Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 16, 2020 11:30 A.M.
Form: S-3
CIK: 0001720725
Company Name: Oyster Point Pharma, Inc.
File Number: 333-249881